Jan 25 2024
Psilocybin mushrooms “could prove to be revolutionary in treating depression and become an alternative medication to SSRI”, finds a new study. Titled Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults – A Systematic Review, the study was published in the journal Clinical Psychopharmacology and Neuroscience. The study was conducted by researchers at Keele …
Jan 25 2024
According to a new study, a strong majority of those in Canada support legislation legalizing the medical use of psilocybin, while an even higher percent support its use for end-of-life care. Titled Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey, the study is published in the journal …
Jan 25 2024
Treatment with a spray containing both CBD and THC “does not impair skills relevant to driving in those patients with tic disorders”, according to a new study. The study found that not only did the spray not impair skills, it “even improved fitness to drive in a subset of patients who were unfit to drive …
Jan 23 2024
The marijuana compound cannabidiol (CBD) showed strong antimicrobial effects in a newly published study. The study will be published in the upcoming issue of the journal Cannabis and Cannabinoid Research, with the abstract published online ahead of print by the US National Library of Medicine. The study is titled Antimicrobial Effect of Cannabidiol on Intracellular …
Jan 22 2024
According to a new study the use of cannabidiol (CBD) may be effective in mitigating stress in dogs who have to routinely travel via motor vehicle. The study, titled Daily dosing of cannabidiol (CBD) demonstrates a positive effect on measures of stress in dogs during repeated exposure to car travel, was published in the Journal …
Jan 14 2024
Combination medical marijuana and opioid therapy “showed statistically significant pain relief and may have the potential for reducing opioid dose and mitigating opioid toxicity”, states a new study. The study is being published in the American Journal of Hospice and Palliative Medicine, with the abstract published online ahead of print by the US National Library …
Jan 11 2024
Researchers at Stanford Medicine have found that ibogaine, a plant-based psychoactive compound, “safely led to improvements in depression, anxiety and functioning among veterans with traumatic brain injuries.” According to a Stanford press release, “researchers have discovered that the plant-based psychoactive drug ibogaine, when combined with magnesium to protect the heart, safely and effectively reduces PTSD, …
Jan 11 2024
According to a new study published in the Journal of Psychopathology and Clinical Science, the use of marijuana over several decades is not associated with a significantly elevated risk of either psychiatric disorders, cognitive decline, or other adverse psychosocial outcomes. For the study researchers at the University of Minnesota and the University of Colorado examined …
Jan 08 2024
When a state legalizes marijuana, colleges in that state see a large increase in applicants, according to a recently published study. The study was conducted by researchers at Oxford College and the University of South Carolina, and it published in the peer-reviewed journal Contemporary Economic Policy with the title Higher education: The impact of recreational …
Jan 06 2024
A new study has found that the marijuana compound cannabidiol (CBD) may be a potential option for combatting nicotine addiction. The study was published in the Journal of Affective Disorders, and it was conducted by researchers at the University of California Irvine and Virginia Commonwealth University. The study is titled Cannabidiol as a potential cessation …
